PRASAD RAJU (Chief Financial Officer) sold 19.2% of their position (3.71K shares) of CRISPR THERAPEUTICS AG on the open market
Open‑market sale worth $173.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/24/2026ACC: 0001193125-26-122268
Officer· Chief Financial Officer
Since Mar 2023
+62.29K
Net shares
Net buyer
$173.5K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
72.25K acquired · 9.96K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
48.0%
3/20/2026
13.02K→19.27K
Common Shares
Direct
Shares
−3.71K
Price / share
$46.78
Trade value
$173.46K
% of position
19.2%
3/23/2026
19.27K→15.56K
Total
Net shares
+2.54K
Net value
-$173.46K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/20/2026 | M · Option Exercise | +6.25K | — | — | 48.0% | 13.02K | 19.27K |
| Common Shares Direct | 3/23/2026 | S · Sale | −3.71K | $46.78 | $173.46K | 19.2% | 19.27K | 15.56K |
| Total | +2.54K | -$173.46K | ||||||
Derivative Transactions3
Stock Option (Right to Buy)
Direct
Converts to
Common Shares
38.50K shares
Shares
+38.50K
Strike price
46.24
Held after
38.50K
Exercisable
—
3/20/2026
Restricted Stock Units
Direct
Converts to
Common Shares
27.50K shares
Shares
+27.50K
Strike price
Held after
27.50K
Exercisable
—
3/20/2026
Restricted Stock Units
Direct
Converts to
Common Shares
6.25K shares
Shares
−6.25K
Strike price
Held after
12.50K
Exercisable
—
3/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Shares38.50K shares | 3/20/2026 | A · Award | +38.50K | 46.24 | — | 38.50K |
| Restricted Stock Units Direct | Common Shares27.50K shares | 3/20/2026 | A · Award | +27.50K | — | 27.50K | |
| Restricted Stock Units Direct | Common Shares6.25K shares | 3/20/2026 | M · Option Exercise | −6.25K | — | 12.50K |